Skip to main content
SpringerLink
Log in

Short Communications: Ovarian Hyperstimulation After the Sole Use of a Gonadotrophin-Releasing Hormone Agonist (Nafarelin) as a Complication of In Vitro Fertilisation Treatment

  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. Quintans CJ, Donaldson MJ, Blanco LA, Pasqualini RS: Empty follicle syndrome due to human errors: Its occurrence in an invitro fertilization programme. Hum Reprod 1998;13:2703-2705

    Google Scholar 

  2. Awonuga A, Govindbahi J, Zierke S, Schnauffer K: Continuing the debate on empty follicle syndrome: Can it be associated with normal bioavailability of-human chorionic gonadotropin on the day of oocyte recovery? Hum Reprod 1997;13:1281-1284

    Google Scholar 

  3. Nduwke G, Thorton S, Fishel S, Dowell K, Aloum M, Green S: Curing the empty follicle syndrome. Hum Reprod 1997;12:21-23.

    Google Scholar 

  4. Coulam CB, Bustillo M, Schulman JD: Empty follicle syndrome. Fertil Steril 1986;46:1153-1155

    Google Scholar 

  5. Zeger-Hochschild F, Fernandez E, MacKenna A, Fabres C, Altieri E, Lopez T: The empty follicle syndrome: A pharmaceutical industry syndrome. Hum Reprod 1995;10:2262-2265

    Google Scholar 

  6. Hassan HA, Saleh HA, Khalil O, Baghdady I, Ismaiel I: Double oocyte aspiration may be a solution for empty follicle syndrome: Case report. Fertil Steril 1998;69:138, 139

    Google Scholar 

  7. Sampaio M, Serra V, Miro F, Calatayud C, Castellvi RM, Pellicer A: Development of ovarian cysts during gonadotrophin releasing hormone agonists (GnRHa) administration. Hum Reprod 1991;6:194-197

    Google Scholar 

  8. Feldberg D, Ashkenazi J, Dicker D, Yeshaya A, Goldman GA, Goldman JA: Ovarian cyst formation: A complication of gonadotropin releasing hormone agonist therapy. Fertil Steril 1989;51:42-45

    Google Scholar 

  9. Weissman A, Barash A, Shapiro H, Casper RF: Ovarian hyperstimulation following the sole administration of agonistic analogues of gonadotrophin releasing hormone. Hum Reprod 1998;13:3421-3424

    Google Scholar 

  10. Parinaud J, Oustry P, Bussenot I, Tourre A, Perineau M, Plantavid M, Monrozies X, Reme J-M, Pontonnier G: Paradoxical ovarian stimulations in the use of LHRH analogs. Eur J Obstet Gynecol Reprod Biol 1992;46:117-122

    Google Scholar 

  11. Khalaf Y, Anderson H, Taylor A, Braude P: Two rare events in one patient undergoing assisted conception: Empty follicle syndrome and ovarian hyperstimulation with the sole administration of a gonadotropin-releasing hormone agonist. Fertil Steril 2000;73:171-172

    Google Scholar 

  12. Albano C, Felberbaum RE, Smitz J, Riethmuller-Winzen H, Engel J, Diedrich K, Devroey P: Ovarian stimulation with HMG: Results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRHagonist buserelin. European Cetrorelix Study Group. Hum Reprod 2000;15(3):526-531

    Google Scholar 

  13. Yeh J, Barbieri, RL, Ravnikar VA: Ovarian hyperstimulation associated with the sole use of Leuprolide for ovarian suppression. J In Vitro Fertil Embryo Transfer 1989;6:261-263

    Google Scholar 

  14. Shalev E, Matilsky M, Geselevich Y: Ovarian hyperstimulation syndrome after administration of gonadotropin-releasing hormone agonist (Abstract 83, Presented at the 4th International Symposium on GnRH Analogues in Cancer and Human Reproduction, Geneva, Switzerland, February 8-11, 1996). Gynecol Endocrinol 1996;10:41

    Google Scholar 

  15. Keltz MD, Jones EE, Duleba AJ, Polcz T, Kennedy K, Olive DL: Baseline cyst formation after luteal phase gonadotropinreleasing hormone agonist administration is linked to poor in vitro fertilization outcome. Fertil Steril 1995;64:568-572

    Google Scholar 

  16. Felberbaum R, Diedrich K: Ovarian stimulation for in-vitro fertilization/intracytoplasmic sperm injection with gonadotrophins and gonadotrophin-releasing hormone analogues: Agonists and antagonists. Hum Reprod 1999;14(Suppl 1):207-221

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Assisted Conception Unit, Simpsons Memorial Maternity Pavilion, Royal Infirmary of Edinburgh, Edinburgh, EH3 9EF, Scotland, United Kingdom

    S. Brett, P. Y. K. Yong & K. J. Thong

Authors
  1. S. Brett
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Y. K. Yong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. J. Thong
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brett, S., Yong, P.Y.K. & Thong, K.J. Short Communications: Ovarian Hyperstimulation After the Sole Use of a Gonadotrophin-Releasing Hormone Agonist (Nafarelin) as a Complication of In Vitro Fertilisation Treatment. J Assist Reprod Genet 18, 353–356 (2001). https://doi.org/10.1023/A:1016680504614

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1016680504614

Keywords

Search

Navigation